NEW YORK(GenomeWeb) – Premier Biosoft and Bruker said today that they have entered a reselling agreement under which Bruker will co-market and resell Premier's SimLipid and SimMet informatics software.
SimLipid and SimMet are intended for mass spec-based analysis of, respectively, lipids and metabolites and facilitate automated LC-MS and MS/MS data processing workflows and identification and quantitation of these analytes, the companies said.
"With this collaboration, we hope to address several of the challenges in advanced biomarker and translational research," Aiko Barsch, market manager at Bruker, said in a statement.
Financial and other terms of the agreement were not disclosed.